Pembrolizumab with sacituzumab govitecan instead of chemotherapy led to improved progression-free survival in PD-L1-postive ...

Vincent Picozzi, MD, medical oncologist and director of the Pancreaticobiliary Program at Virginia Mason, discusses findings ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

Cancer remains one of the biggest health challenges of our lifetime. Millions of people globally receive a cancer diagnosis each year — in the United States, that’s about one diagnosis every 30 ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

The first of two new University of Kansas Cancer Center clinics is wrapping up construction and readying to open in two weeks ...

The FDA has granted a third approval for WELIREG, authorizing its use as a treatment for patients with rare endocrine system tumors known as ...

The National Comprehensive Cancer Network (NCCN) announces 2025 awardees who go above and beyond to define and advance ...

Becker's Hospital Review released a first-of-its-kind list at the end of April, noting Tampa General Hospital (TGH) as one of the top 100 academic medical centers to know in 2025. This latest accolade ...